Britain has announced a funding package worth around £600 million to strengthen national defences against emerging artificial intelligence threats, placing cybersecurity, biological safety and AI risk research at the centre of its technology strategy.
Announced on 24 October, the investment forms part of the government’s wider ambition to develop domestic AI capabilities while reducing the country’s dependence on technology developed overseas. The package comes as policymakers face growing questions about whether existing security systems can keep pace with increasingly capable AI tools. At the heart of the announcement is a £165 million National AI Biosecurity Initiative, including £100 million in government funding for a new AI Biosecurity Lab and £65 million to strengthen biological surveillance and develop medical countermeasures against priority pathogens.
The government says the laboratory will use advanced AI systems to identify potential biological threats earlier and accelerate research into vaccines, treatments and other medical responses. AI Minister Kanishka Narayan said the new institution would bring together leading scientific expertise to protect people from emerging biological threats and help Britain establish a stronger position in AI safety and security.
From cyberattacks to biological risks
The funding extends beyond public health. The government has committed an additional £120 million to the AI Security Institute, which tests advanced AI systems, studies their capabilities and risks, and develops technical approaches to improve safety. Another £60 million will support a National Cyber Shield, designed to use AI to strengthen the country’s cyber defences. A further £70 million will establish a National Exposure and Real-Time Vulnerability Centre to identify weaknesses across critical infrastructure and the wider economy.
These investments reflect a central concern for security officials: AI could help defenders detect vulnerabilities more quickly, but increasingly capable systems may also give malicious actors new ways to exploit them. The government’s announcement describes resilience against cyber, biological and other AI-enabled threats as essential to realising the technology’s economic benefits.
Big technology firms join the biosecurity effort
The proposed AI Biosecurity Lab will receive up to £200 million in additional commitments from OpenAI and Anthropic, taking its announced backing to as much as £300 million.
According to the Cabinet Office, OpenAI will provide £100 million in computing and model credits, alongside trusted access to relevant AI models. Anthropic has committed up to £100 million in model credits, trusted model access and technical support.
Google DeepMind and UK-based Basecamp Research are also expected to collaborate with the laboratory on scientific research and AI tools. The government intends the independent, non-profit organisation to bring together expertise from AI developers, life sciences researchers and public-sector biosecurity agencies.
However, the distinction between public spending and private-sector contributions is important: the laboratory’s £300 million backing is not entirely government cash. The corporate commitments include computing resources and access to AI models rather than simply direct financial payments.
Can AI become part of the solution?
The government argues that the same technology creating new risks could also help address them. AI-assisted research could improve the early detection of biological threats and speed up the development of treatments when new diseases emerge.
Chancellor John Healey said AI could transform businesses, communities, hospitals, schools and the wider economy. He also acknowledged workers’ concerns and promised an approach intended to ensure people are not left behind as the technology develops. Alongside security spending, the wider package includes additional support for British AI companies, industrial technology and research, as well as initiatives intended to prepare the workforce for changes in employment.
Questions remain over delivery
The announcement signals a significant expansion of Britain’s AI security ambitions, but funding alone will not establish whether the measures succeed. Their effectiveness will depend on how quickly the new institutions become operational, how well public agencies coordinate with private developers, and whether safeguards keep pace with technological advances.
The government has yet to set out every operational detail of the new laboratory, including its full governance arrangements and scientific advisory structure.
For Britain, the challenge is becoming increasingly clear: securing the benefits of AI will require more than encouraging innovation. It will also mean identifying emerging threats before they become real-world crises. The latest investment represents a major step in that direction. Whether it delivers stronger protection for the public will depend on what happens next.
